SciELO - Scientific Electronic Library Online

 
vol.95 número3Staphylococcus lugdunensis endocarditis causing prosthetic aortic valve dysfunction after TAVRConexión anómala de venas pulmonares supracardiacas: el valor de la resonancia magnética cardiaca y el uso del flujo 4D en su evaluación índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Archivos de cardiología de México

versión On-line ISSN 1665-1731versión impresa ISSN 1405-9940

Arch. Cardiol. Méx. vol.95 no.3 Ciudad de México jul./sep. 2025  Epub 22-Ago-2025

https://doi.org/10.24875/acm.24000157 

Images in cardiology

Lambl’s excrescence on the aortic valve

Excrecencia de Lambl en la válvula aórtica

José M. Alanís-Naranjo1  * 

Elvira Flores-Ibarra1 

Carlos Á. Monterrey-García1 

Cielmar Galeana-Abarca1 

Julio C. Rivera-Hermosillo1 

1Department of Cardiology, Hospital Regional 1° de Octubre, ISSSTE, Mexico City, Mexico


A 29-year-old female with systemic lupus erythematosus was admitted due to persistent fever. Imaging studies and transthoracic echocardiography (TTE) were non-diagnostic for infectious foci. Salmonella Typhi was detected in three separate blood cultures, and an intravenous antibiotic was prescribed; however, the fever persisted and the blood cultures remained positive. Transesophageal echocardiography (TEE) revealed a low-density, thin, hypermobile, filiform lesion on the ventricular surface of the aortic valve, consistent with Lambl’s excrescence (LE) (Fig. 1A-E). Despite the TEE findings, the infectious disease department switched antibiotics, alleviating symptoms and resolving the fever. On the 14th day, blood cultures were negative, whereas follow-up TEE revealed no change in the filamentous structure. The patient was discharged symptom-free and completed 6 weeks of oral antibiotics without recurrence of fever. A 6-month follow-up TEE revealed no changes in the mobile structure or evidence of valvular disease (Fig. 1F and G).

Figure 1 TEE shows Lambl’s excrescence on the aortic valve. Initial TEE (yellow arrow): A: mid-esophageal long axis view depicting a filamentous structure attached to the ventricle surface of the aortic valve; B and C: 3-D reconstruction; D and E: mid-esophageal long axis view in X-plane mode demonstrating the mobile structure in the left ventricular outflow tract. Follow-up TEE, 6 months later, showing no change in the linear mobile structure (green arrow): F: mid-esophageal long-axis view and G: mid-esophageal aortic valve short-axis view in X-plane mode. TEE: transesophageal echocardiogram. 

Dr. Vilém Dušan Lambl first described LEs in 1856. Usually located at the Arantius nodules, these filiform structures (≤ 2mm thick and ≥ 3mm long), with hypermobility, originate at the closure margins of valve leaflets1,2. LEs are most common on the atrial surface of the mitral valve (68-76%) and the ventricular surface of the aortic valve (38-50%), and are rarely seen on native right-sided valves and prosthetic valves1,3. Endothelial injury caused by valvular wear and tear contributes to excrescence development1,2. The majority of LEs are asymptomatic and are found incidentally during echocardiography or autopsy2,3. Nevertheless, they are considered rare causes of thromboembolism, usually due to fragmentation or microthrombus formation on top of the lesions, more often in the excrescences of the aortic valve. TEE remains the gold standard for diagnosis, with greater sensitivity and specificity than TTE1,2. In light of the rarity of LEs, there is no standard management guideline2,3; asymptomatic patients should be closely monitored and followed up with TEE3, while patients with embolic events should be managed individually, considering antiplatelets, anticoagulants or surgery2,3. LEs should be considered in the differential diagnosis of infective endocarditis and other cardiac masses, with close monitoring and follow-up TEE in asymptomatic patients.

References

1. Ammannaya GK. Lambl's excrescences:current diagnosis and management. Cardiol Res. 2019;10:207-10. [ Links ]

2. Alajjuri MA, Alajjuri OA, Alani FR. Lambl's excrescence as an etiology of thromboembolism:case report and literature review. Clin Med Insights Case Rep. 2023;16:1-6. [ Links ]

3. Shrestha B, Pokhrel A, Oke I, Paudel A, Timlisina B, Parajuli P, et al. Lambl's excrescences associated with cardioembolic stroke. Am J Case Rep. 2022;23:e934859. [ Links ]

FundingThis research has not received any specific grant from agencies in the public, commercial, or for-profit sectors.

Ethical considerations

Protection of humans and animals. The authors declare that no experiments involving humans or animals were conducted for this research.

Confidentiality, informed consent, and ethical approval. The authors have followed their institution’s confidentiality protocols, obtained informed consent from patients, and received approval from the Ethics Committee. The SAGER guidelines were followed according to the nature of the study.

Declaration on the use of artificial intelligence. The authors declare that no generative artificial intelligence was used in the writing of this manuscript.

Received: August 27, 2024; Accepted: January 31, 2025

* Correspondence: José M. Alanís-Naranjo E-mail: martin.alanis.n@gmail.com

Conflicts of interest

The authors declare no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license